This Guide provides practical guidance for governments regarding how to effectively communicate with communities during the recovery phase following an emergency. It explains how to identify communication needs, and presents “best fit” communication methods and strategies to deploy to support Di...saster Recovery Frameworks (DRF) and recovery strategies.
The Guide is divided into six sections, as follows:
SECTION 1 Good Practice Principles for Effective Communication
SECTION 2 Barriers to Effective Communication
SECTION 3 How to Identify Communication Needs during Recovery
SECTION 4 Communication Methods for Recovery Planning and Operations
SECTION 5 Developing a Communication Plan
SECTION 6 Key Take-away Messages
more
3rd Edition – July 2017
www.msfaccess.org
РУКОВОДСТВО ПО
ДОПОЛНЕНИЕ К СВОДНОМУ РУКОВОДСТВУ ПО УСЛУГАМ ТЕСТИРОВАНИЯ НА ВИЧ
ДЕКАБРЬ 2016 г.
УСЛУГИ ТЕСТИРОВАНИЯ НА ВИЧ
This technical brief was developed by the UNFPA Global Ageing Network to complement the UN Department of Economic and Social Affairs' (UN DESA) Issue Brief: Older Persons and COVID-19, which emphasized the humanitarian imperative of addressing older persons' specific needs within preparedness and re...sponse to the COVID-19 pandemic.
more
Presentation on WASH in Malawi
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
PLOS ONE | DOI:10.1371/journal.pone.0155525 May 19, 2016, 1 / 11
Integritas 4.3 (Fall 2014), pp. 1-30.
doi: 10.6017/integritas.v4i3p1
Обобщены результаты региональных исследований распространенности болезни Паркинсона (БП) и заболеваемости ею в России; выявлены основные факторы, определяющие к...чество оценок эпидемиологических показателей болезни. Источниками для обзора послужили 19 оригинальных работ по эпидемиологии паркинсонизма и болезни Паркинсона в России, опубликованные в период 2005–2015 гг.
http://www.ssmj.ru/system/files/2016_03_379-384.pdf
more
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future... supply security. In 2021, the AU set a target to produce and supply more than 60% of the vaccine doses on the continent by 2040.
In the last 18 months alone, more than 30 new African manufacturing projects have been announced and estimates indicate that the African vaccine market across all existing and projected novel products could range between US$ 2.8 billion and US$ 5.6 billion by 2040*, demonstrating the potential for a thriving regional industry to emerge.
more
15. Euro Surveill. 2017;22(47):pii=17-00103
March – June 2020
This update: 3 April 2020